Collectively, these compelling findings underscore the pivotal role of the JUN, HIF1A, and PTGS2 genes as promising clinical prognostic markers for patients grappling with gastric cancer, heralding a paradigm shift in personalized prognostication strategies within the oncological landscape. The gene discussed is HIF1A; the disease is gastric cancer.